Amoxicillin And Clavulanate Potassium
Product Images NDC 53002-2392

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 53002-2392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amoxiciilin Structure (Coamoxicillin Strc1)

Chemical structure of amoxicillin and clavulanate potassium. The diagram displays the molecular arrangement of the active ingredients in AMOXICILLIN AND CLAVULANATE POTASSIUM.*

FDA Label Image

Clavunate Potassium Structure (Coamoxicillin Strc2)

Chemical structure of amoxicillin, showing its beta-lactam core with attached hydroxymethyl and carboxylate functional groups, consistent with the active ingredient in amoxicillin and clavulanate potassium.*

FDA Label Image

Label Image (Lbl530022392)

AMOXICILLIN AND CLAVULANATE POTASSIUM 500 mg / 125 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates the dosage form as tablets with a quantity of 20 tablets. Instructions include taking one tablet twice daily for 10 days or as directed. The label displays lot number, manufacture, and expiration dates, with space for clinic name and patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.